NovaBay Pharmaceuticals Inc
NBY1.060USD
-0.040-3.64%
終値 11/04, 16:00（ET）15分遅れの株価
6.17M時価総額
2.66直近12ヶ月PER
詳細情報 NovaBay Pharmaceuticals Inc 企業名
NovaBay Pharmaceuticals, Inc. is engaged in wound care products. The Company manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.
NovaBay Pharmaceuticals Incの企業情報
企業コードNBY
会社名NovaBay Pharmaceuticals Inc
上場日Oct 26, 2007
最高経営責任者「CEO」Mr. David E. Lazar
従業員数14
証券種類Ordinary Share
決算期末Oct 26
本社所在地2000 Powell St Ste 1150
都市EMERYVILLE
証券取引所NYSE American Consolidated
国United States of America
郵便番号94608-1804
電話番号15108998800
ウェブサイトhttps://novabay.com/
企業コードNBY
上場日Oct 26, 2007
最高経営責任者「CEO」Mr. David E. Lazar
NovaBay Pharmaceuticals Incの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Ms. Swan Sit
Ms. Swan Sit
Independent Director
Independent Director
933.00
+914.13%
Mr. Justin M. Hall, Esq.
Mr. Justin M. Hall, Esq.
Vice President - Business Development, General Counsel, Corporate Secretary
Vice President - Business Development, General Counsel, Corporate Secretary
67.00
-88.45%
Mr. Paul E. Freiman, Ph.D.
Mr. Paul E. Freiman, Ph.D.
Director
Director
--
--
Dr. Yenyou (Jeff) Zheng, Ph.D.
Dr. Yenyou (Jeff) Zheng, Ph.D.
Independent Director
Independent Director
--
--
Mr. Tommy Law
Mr. Tommy Law
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
--
-100.00%
Capt. Jody Cain
Capt. Jody Cain
IR Contact Officer
IR Contact Officer
--
--
Mr. Michael Kazley
Mr. Michael Kazley
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Ms. Swan Sit
Ms. Swan Sit
Independent Director
Independent Director
933.00
+914.13%
Mr. Justin M. Hall, Esq.
Mr. Justin M. Hall, Esq.
Vice President - Business Development, General Counsel, Corporate Secretary
Vice President - Business Development, General Counsel, Corporate Secretary
67.00
-88.45%
Mr. Paul E. Freiman, Ph.D.
Mr. Paul E. Freiman, Ph.D.
Director
Director
--
--
Dr. Yenyou (Jeff) Zheng, Ph.D.
Dr. Yenyou (Jeff) Zheng, Ph.D.
Independent Director
Independent Director
--
--
Mr. Tommy Law
Mr. Tommy Law
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
--
-100.00%
Capt. Jody Cain
Capt. Jody Cain
IR Contact Officer
IR Contact Officer
--
--
収益内訳
通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
事業別USD
会社名
収益
比率
Avenova
8.67M
88.67%
Other products
1.07M
10.98%
Other revenue, net
34.00K
0.35%
NeutroPhase
0.00
0.00%
地域別USD
会社名
収益
比率
United States
9.78M
100.00%
事業別
地域別
事業別USD
会社名
収益
比率
Avenova
8.67M
88.67%
Other products
1.07M
10.98%
Other revenue, net
34.00K
0.35%
NeutroPhase
0.00
0.00%
株主
更新時刻: Sat, Oct 18
更新時刻: Sat, Oct 18
株主統計
種類
株主統計
株主統計
比率
Poplar Point Capital Management LLC
16.99%
C2C Wealth Management, LLC
1.63%
The Vanguard Group, Inc.
0.99%
Geode Capital Management, L.L.C.
0.56%
Rangeley Capital LLC
0.55%
他の
79.28%
株主統計
株主統計
比率
Poplar Point Capital Management LLC
16.99%
C2C Wealth Management, LLC
1.63%
The Vanguard Group, Inc.
0.99%
Geode Capital Management, L.L.C.
0.56%
Rangeley Capital LLC
0.55%
他の
79.28%
種類
株主統計
比率
Hedge Fund
18.04%
Investment Advisor
3.13%
Investment Advisor/Hedge Fund
0.56%
Venture Capital
0.34%
Individual Investor
0.09%
他の
77.83%
機関投資家保有株
更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
37
1.33M
22.07%
-126.95K
2025Q2
43
1.43M
24.52%
+210.59K
2025Q1
42
1.34M
22.96%
+376.59K
2024Q4
40
546.91K
11.19%
+390.20K
2024Q3
42
126.44K
2.60%
+79.02K
2024Q2
44
12.01K
0.89%
-33.08K
2024Q1
44
12.73K
1.48%
-22.10K
2023Q4
45
34.29K
18.48%
+25.73K
2023Q3
47
15.18K
15.11%
-444.00
2023Q2
47
9.53K
10.53%
-5.30K
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Poplar Point Capital Management LLC
1.02M
16.99%
--
--
Sep 03, 2025
C2C Wealth Management, LLC
98.00K
1.63%
+43.00K
+78.18%
Jun 30, 2025
The Vanguard Group, Inc.
270.00
0%
--
--
Aug 31, 2025
Geode Capital Management, L.L.C.
33.82K
0.56%
-1.17K
-3.35%
Jun 30, 2025
Rangeley Capital LLC
33.21K
0.55%
+33.21K
--
Jun 30, 2025
Two Sigma Investments, LP
24.28K
0.4%
+6.81K
+38.96%
Jun 30, 2025
XTX Markets LLC
20.31K
0.34%
+463.00
+2.33%
Jun 30, 2025
Tower Research Capital LLC
5.45K
0.09%
-6.00
-0.11%
Jun 30, 2025
UBS Financial Services, Inc.
3.38K
0.06%
+2.64K
+351.94%
Jun 30, 2025
詳細を見る
関連ETF
更新時刻: Sun, Nov 2
更新時刻: Sun, Nov 2
銘柄名
比率
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
比率0%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
Apr 18, 2024
Merger
35→1
Apr 18, 2024
Merger
35→1
Apr 18, 2024
Merger
35→1
Apr 18, 2024
Merger
35→1
Nov 14, 2022
Merger
35→1
Nov 14, 2022
Merger
35→1
日付
種類
比率
Apr 18, 2024
Merger
35→1
Apr 18, 2024
Merger
35→1
Apr 18, 2024
Merger
35→1
Apr 18, 2024
Merger
35→1
Nov 14, 2022
Merger
35→1
Nov 14, 2022
Merger
35→1
Nov 14, 2022
Merger
35→1
Nov 14, 2022
Merger
35→1
